Pregnancy: Pregestational and Gestational Management

  • María Isabel García-Argueta
  • Maricela González-Espejel


Gestational diabetes (GD) is a complication of pregnancy with an incidence of up to 16%, characterized by alteration in carbohydrate metabolism. It is a condition that favors greater risk of developing complications such as congenital malformations, stillbirth, preeclampsia, fetal macrosomia, polyhydramnios, greater index of cesareans, and hemorrhagic complications that it brings. Its etiology is multifactorial, including genetic determinants such as ethnicity; lifestyle, where sedentary lifestyle plays the most important role; easy access to high-caloric foods; and the socioeconomic level, where the lower strata have the highest risk. Diagnosis is easy to perform from the identification of women of reproductive age with risk factors and from the first prenatal visit, by measuring blood glucose. General measures such as lifestyle and diet modification of the pregnant patient are the beginning of treatment. In the case of not reaching control of glucose levels, oral hypoglycemic drug and insulin are the basis of treatment with the object of maximum reduction of complications for both mother and neonate.


Diabetes Pregnancy Gestational diabetes Obesity Pregnancy outcomes 




The American College of Obstetricians and Gynecologists.


The American Diabetes Association.


Is the result of dividing the weight of a person in kilograms by the square of his height in meters.

Congenital malformations

are anatomic alterations that occur in the intrauterine stage and may be alterations in organs, extremities or systems, due to environmental, genetic factors, deficiencies in nutrient capture, or consumption of noxious substances.


National Health and Nutrition Survey 2012 (Mexico).


The Food and Drug Administration.

Fetal macrosomia

Traditionally, fetal macrosomia has been defined as arbitrary weight at birth, such as 4000, 4100, 4500, or 4536 grams. It is currently defined as a fetus that is large for gestational age (> 90 percentile).


Gestational diabetes, which is defined as alteration in carbohydrate metabolism diagnosed for the first time in the second or third trimester of gestation.

HAPO Study

Hyperglycemia and Adverse Pregnancy Outcomes study.


The International Association of Diabetes and Pregnancy Study Groups.


From the Latin “isla.” It is a polypeptide hormone formed by 51 amino acids, produced and secreted by the beta cells of the Islets of Langerhans of the pancreas. Discovered by Frederick Grant Banting, Charles Best, James Collip, and J.J.R. Macleod of the University of Toronto, Canada in 1921.


National Institutes of Health.


Obesity and overweight are defined as abnormal or excessive accumulation of fat that may prejudice health. A simple way to measure obesity is the body mass index (BMI), which is the weight of a person divided by height in meters squared. A person with BMI equal or above 30 is considered obese and with a BMI equal or greater than 25 is considered overweight.

Oral hypoglycemic drugs

Antidiabetic drugs which are classified as sulfonylureas, biguanides, alpha-glucosidase inhibitors, meglitinides (repaglinide, nateglinide) and thiazolidinediones.

Perinatal mortality

is the fetus and newborn risk of dying as a consequence of the reproductive process.

Premature birth

According to WHO, birth that occurs after week 20 and before 37 complete weeks.


Type 1 diabetes, which is secondary to the destruction of the beta cells of the pancrease, and in general leads to absolute insulin deficiency.


Type 2 diabetes, which is due to a progressive loss of insulin secretion.


World Health Organization.

Women of reproductive age

Women between 15 and 44 years.


  1. 1.
    Liat S, Cabrero L, Hod M, Yogev Y. Obesity in obstetrics. Best Pract Res Clin Obstet and Gynaecol. 2015;29:79–90.CrossRefGoogle Scholar
  2. 2.
    Aviram A, Hod M, Yogev Y. Maternal obesity: implications for pregnancy outcome and long-term risks—a link to maternal nutrition. Int J Gynecol Obstet. 2011;115(Suppl 1):S6–S10.CrossRefGoogle Scholar
  3. 3.
    Albrecht SS, Barquera S, Popkin BM. Exploring secular changes in the association between BMI and waist circumference in Mexican-Origin and White women: a comparison of Mexico and the United States. Am J of Hum Biol. 2014;26:627–34.CrossRefGoogle Scholar
  4. 4.
    ACOG. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol. 2013;122(2 Pt 1):406–16.Google Scholar
  5. 5.
    McCance DR. Diabetes in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015;29:685–99.CrossRefGoogle Scholar
  6. 6.
    Lawrence JM. Women with diabetes in pregnancy: different perceptions and expectations. Best Pract Res Clin Obstet Gynaecol. 2011;25:15–24.CrossRefGoogle Scholar
  7. 7.
    Crume TL, Ogden L, West NA, et al. Association of exposure to diabetes in utero with adiposity and fat distribution in a multiethnic population of youth: The Exploring Perinatal Outcomes among Children (EPOCH) Study. Diabetologia. 2011;54:87–92.CrossRefGoogle Scholar
  8. 8.
    Hadar E, Ashwal E, Hod M. The preconceptional period as an opportunity for prediction and prevention of non-communicable disease. Best Pract Res Clin Obstet Gynaecol. 2015;29:54–62.CrossRefGoogle Scholar
  9. 9.
    American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In standards of medical care in diabetes 2016. Diabetes Care. 2016;39(Suppl. 1):S13–22.Google Scholar
  10. 10.
    Sacks DA, Metzger BE. Classification of diabetes in pregnancy. Time to reassess the alphabet. Obstet Gynecol. 2013;121(2):345–8.CrossRefGoogle Scholar
  11. 11.
    The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.CrossRefGoogle Scholar
  12. 12.
    Ogunyemi DA, Fong A, Rad S, Fong S, Kjos SL. Attitudes and practices of health care providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG). Diabet Med. 2011;28(8):976–86.CrossRefGoogle Scholar
  13. 13.
    Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomes – a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;12:23. Scholar
  14. 14.
    McIntyre HD, Metzger BE, Coustan DR, et al. Counterpoint: establishing consensus in the diagnosis of GDM following the HAPO study. Curr Diab Rep. 2014;14:497.CrossRefGoogle Scholar
  15. 15.
    American Diabetes Association. Management of diabetes in pregnancy. Sec. 12. In standards of medical care in diabetes. Diabetes Care. 2016;39(Suppl 1):S94–8.Google Scholar
  16. 16.
    Buchanan TA. Intermediary metabolism durin pregnancy: implication for diabtes mellitus. En: Le Roith D, Olefsky JM, Tyalor SI. Diabetes mellitus: a fundamental and clinical text (3). Philadelphia: Wolters Kluwer Health; 2003. Pro Quest Library. pp. 1237–50.Google Scholar
  17. 17.
    Buchanan TA. Effects of maternal diabetes mellitus on intrauterine development. En: Le Roith D, Olefsky JM, Tyalor SI. Diabetes mellitus: a fundamental and clinical text (3). Philadelphia: Wolters Kluwer Health; 2003. Pro Qeust ebrary. pp. 1251–64.Google Scholar
  18. 18.
    Tessier DR, Ferraro ZM, Gruslin A. Role of leptin in pregnancy: consequences of maternal obesity. Placenta. 2013;34:205–11.CrossRefGoogle Scholar
  19. 19.
    Guía de Práctica Clínica. Diagnóstico y Tratamiento de la Diabetes en el Embarazo. México: Secretaria de Salud; 2009.Google Scholar
  20. 20.
    Berggren EK, Boggess KA. Oral agents for the management of gestational diabetes. Clinical Obstet GynecolLippincott Williams and Wilkins. 2013;56(4):827–36.CrossRefGoogle Scholar
  21. 21.
    Spaulonci CP, Bernardes LS, Trindade TC, et al. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol. 2013;209:34. e1–7.CrossRefGoogle Scholar
  22. 22.
    Zhao LP, Sheng XY, Zhou S, Yang T, Ma LY, Zhou Y, Cui YM. Metformin versus insulin for gestational diabetes mellitus: a meta-analysis. Br J Clin Pharmacol. 2015;80(5):1224–34.CrossRefGoogle Scholar
  23. 23.
    Singh AK, Singh R. Metformin in gestational diabetes: an emerging contender. Indian J Endocrinol Metab. 2015;19(2):236–44.CrossRefGoogle Scholar
  24. 24.
    Korkmazer E, Solak N, Tokgöz VY. Gestational diabetes: screening, management, timing of delivery. Curr Obstet Gynecol Rep. 2015;4:132–8.CrossRefGoogle Scholar
  25. 25.
    Benhalima K, Devlieger R, Van Assche A. Screening and management of gestational diabetes. Best Pract Res Clin Obstet Gynaecol. 2015;29:339–49.CrossRefGoogle Scholar
  26. 26.
    Garrison EA, Jagasia S. Inpatient management of women with gestational and pregestational diabetes in pregnancy. Curr Diab Rep. 2014;14:457.CrossRefGoogle Scholar
  27. 27.
    Theodoraki A, Baldeweg SE. Symposium on diabetes. Gestational diabetes mellitus. Br J Hosp Med. 2008;69(10):562–7.CrossRefGoogle Scholar
  28. 28.
    Gunderson EP. Breastfeeding after gestational diabetes pregnancy. Diabetes Care ProQuest. 2007;30(S2):S161–8.CrossRefGoogle Scholar
  29. 29.
    Trout KK, Averbuch T, Barowski M. Promoting breastfeeding among obese women and women with gestational diabetes mellitus. Curr Diab Rep. 2011;11(7):7–12.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • María Isabel García-Argueta
    • 1
  • Maricela González-Espejel
    • 1
  1. 1.72 Regional Hospital, Mexican Institute of Social ServicesMexico CityMexico

Personalised recommendations